报告药物副作用：信号与噪音。 - Suppr | 超能文献

Reporting drug side effects: signals and noise.

作者信息

Avorn J

出版信息

JAMA. 1990 Apr 4;263(13):1823.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Reporting drug side effects: signals and noise.报告药物副作用：信号与噪音。

JAMA. 1990 Apr 4;263(13):1823.

2

Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety.改进美国食品药品监督管理局确保药品上市后安全的授权。

JAMA. 2011 Oct 12;306(14):1595-6. doi: 10.1001/jama.2011.1457.

3

FDA turns to electronic "sentinel" to flag prescription drug safety problems.美国食品药品监督管理局借助电子“哨兵”来标记处方药安全问题。

JAMA. 2008 Jul 9;300(2):156-7. doi: 10.1001/jama.300.2.156.

4

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.医生上报药品不良反应。罗德岛药品不良反应上报项目的结果。

JAMA. 1990 Apr 4;263(13):1785-8.

5

Drug review and postmarketing surveillance programs are sound, but systems approach to risk management is needed, says FDA.美国食品药品监督管理局表示，药品审评和上市后监测计划完善，但仍需采用系统方法进行风险管理。

Am J Health Syst Pharm. 1999 Jul 1;56(13):1294,6. doi: 10.1093/ajhp/56.13.1294.

6

Discovering adverse drug reactions.

JAMA. 1983;249(16):2224-5.

7

Post-marketing surveillance of prescription drug safety: past, present, and future.处方药安全性的上市后监测：过去、现在与未来。

J Leg Med. 2013;34(2):193-213. doi: 10.1080/01947648.2013.800797.

8

The report of the Institute of Medicine on drug safety.

Am J Ther. 2007 Jan-Feb;14(1):1-2. doi: 10.1097/MJT.0b013e31802fb038.

9

National adverse drug reaction surveillance: 1985.国家药品不良反应监测：1985年。

JAMA. 1987 Apr 17;257(15):2068-70.

10

Role of postmarketing surveillance in contemporary medicine.药品上市后监测在当代医学中的作用。

Annu Rev Med. 2011;62:1-10. doi: 10.1146/annurev-med-060309-164311.

引用本文的文献

1

A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.一种基于泊松分布和贝叶斯方法的疑似肝脏药物不良反应患者风险及因果关系判定新方法：两例噻氯匹定所致肝毒性新病例报告

Drug Saf. 2002;25(10):735-50. doi: 10.2165/00002018-200225100-00006.

2

An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.基于证据的肌肉骨骼疾病中开具非甾体抗炎药的方法：加拿大共识。加拿大非甾体抗炎药共识参与者。

CMAJ. 1996 Jul 1;155(1):77-88.

3

Over-the-counter self-medication. The issues.非处方自我药疗。相关问题。

Drugs Aging. 1992 Jul-Aug;2(4):257-61. doi: 10.2165/00002512-199202040-00001.